FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin

Docetaxel is commonly used as an effective chemotherapeutic drug for gastric cancer patients recently. With the increasing emergence of docetaxel resistance nowadays, identification of suitable biomarkers for predicting chemosensitivity to docetaxel may be a key role for improving therapeutic effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoxiao, Yao, Ruyong, Yue, Lu, Qiu, Wensheng, Qi, Weiwei, Liu, Shihai, Yao, Yasai, Liang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119387/
https://www.ncbi.nlm.nih.gov/pubmed/24628949
http://dx.doi.org/10.1111/jcmm.12216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119387/
https://www.ncbi.nlm.nih.gov/pubmed/24628949
http://dx.doi.org/10.1111/jcmm.12216

Ejemplares similares